Who
Ann-Louise Batchelor
Group Chief Marketing Officer
Company insider
Files Form 4 as: Group Chief Marketing Officer, VolitionRX.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Oct 2022
- Last trade
- 21 Oct 2026
- Last filed
- 23 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Oct 2026filed 23 Oct 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —142,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —142,000 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —33,900 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —33,900 at $0.00 | filing |
| 4 Oct 2025filed 7 Oct 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code F | $3,9726,110 at $0.65 | filing |
| 28 Sep 2025filed 30 Sep 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code F | $3,4185,604 at $0.61 | filing |
| 15 Aug 2025filed 19 Aug 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —27,400 at $0.00 | filing |
| 1 Aug 2025filed 5 Aug 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code F | $5,5178,620 at $0.64 | filing |
| 1 Jul 2025filed 3 Jul 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code F | $4,7566,177 at $0.77 | filing |
| 1 Jun 2025filed 3 Jun 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —18,341 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —14,233 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —40,000 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —40,000 | filing |
| 1 Dec 2024filed 3 Dec 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —13,143 at $0.00 | filing |
| 4 Oct 2024filed 8 Oct 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code F | $5,3776,110 at $0.88 | filing |
| 28 Sep 2024filed 1 Oct 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code F | $3,2505,604 at $0.58 | filing |
| 1 Sep 2024filed 4 Sep 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —13,731 at $0.00 | filing |
| 15 Aug 2024filed 16 Aug 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —13,250 at $0.00 | filing |
| 1 Jun 2024filed 4 Jun 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —11,685 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.